Skip to main content
SpringerLink
Log in

Alemtuzumab/cyclophosphamide/fludarabine

EBV-induced B cell lymphoma in elderly patients: 2 case reports

  • Case report
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

REFERENCE

  1. Rigaudeau S, Copie-Bergman C, Boidart F, Garcia I, Taksin AL, Harzic M, Ghez S, Merabet F, Rousselot P, Gaulard P, Castaigne S.Occurrence of EBV induced B cells lymphoma in two patients treated concomitantly with fludarabine, cyclophosphamide and alemtuzumab. Haematologica 92 (Suppl. 1): 454 abstr. 1249, Jun 2007 - France

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Alemtuzumab/cyclophosphamide/fludarabine. React. Wkly. 1170, 7–8 (2007). https://doi.org/10.2165/00128415-200711700-00014

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00128415-200711700-00014

Keywords

Search

Navigation